San Francisco, CA, United States of America

Jason M Casolari

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jason M. Casolari: Innovator in Nucleic Acid Amplification

Introduction

Jason M. Casolari is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of molecular biology, particularly in the detection of human beta actin. His work has implications for various applications in medical diagnostics and research.

Latest Patents

Jason holds a patent for "Polynucleotides for amplification and detection of human beta actin." This patent discloses primers and probes related to the detection of beta actin via nucleic acid amplification testing (NAAT). The technology aims to amplify and determine the presence of β-actin in test samples. Specifically, the patent describes primers and probes that bind to the beta actin gene for detection through loop-mediated isothermal amplification (LAMP) and molecular beacon hybridization. He has 1 patent to his name.

Career Highlights

Jason is currently associated with Talis Biomedical Corporation, where he continues to innovate in the field of biotechnology. His work at Talis Biomedical Corporation focuses on developing advanced diagnostic tools that enhance the accuracy and efficiency of medical testing.

Collaborations

Jason has collaborated with talented individuals such as Xuewen Jiang and Hédia Maamar. These collaborations have contributed to the advancement of his research and the development of innovative solutions in the field.

Conclusion

Jason M. Casolari is a prominent figure in the realm of molecular diagnostics, with a focus on the detection of beta actin. His contributions through patents and collaborations highlight his commitment to advancing medical technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…